
α-asarone reduce proteinuria by restoring antioxidant enzymes activities and regulating necrosis factor κB signaling pathway in doxorubicin-induced nephrotic syndrome
Keywords: DOX; doxorubicin; ESRD; end stage renal disease; SOD; superoxide dismutase; CAT; catalase; XO; xanthine oxidase; TBARS; thiobarbituric acid reactive substances; MDA; malondialdehyde; DCFH-DA; 2â²,7â²-dichlorofuorescein diacetate; DCF; 2â²,7â²-dichloro